Patient survival improved with new therapy
According to lead author, Nicholas J. Vogelzang, M.D., University of Chicago Cancer Research Center:
"This is the largest clinical trial ever conducted in this disease and the 25 to 30 percent improvement in survival for patients on the combination therapy is the first time anyone has documented a significant improvement in patients treated for mesothelioma."
Courtesy of The National Cancer Institute.
NY asbestos lawyers: How does folic acid help Mesothelioma patients?